EAPIF (Euroapi) Buildings And Improvements: $ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EAPIF Euroapi SA EAPIF
53 GF Score
Price $0.97
GF Value $2.84
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Buildings And Improvements?

Euroapi EAPIF 53 Buildings And Improvements is $ Mil as of Jun. 2026. GuruFocus rates EAPIF with a GF Score™ of 53/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 6 warning signs investors should review.

Euroapi's annual buildings and improvements declined from Dec. 2023 ($355.0 Mil) to Dec. 2024 ($309.3 Mil) but then increased from Dec. 2024 ($309.3 Mil) to Dec. 2025 ($368.9 Mil).

Euroapi Buildings And Improvements Historical Data

* Premium members only.

The historical data trend for Euroapi's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Buildings And Improvements Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buildings And Improvements
Get a 7-Day Free Trial 339.57 321.88 355.03 309.30 368.89

Euroapi Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Buildings And Improvements Get a 7-Day Free Trial Premium Member Only - - - - -
EAPIF
53GF Score
Euroapi SA EAPIF
Buildings And Improvements is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction.  Broker and architect fees, permits, etc. can be covered within this category.  Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized.  Improvements are commonly recorded at acquisition cost.  Building improvement examples include roofing, remodeling, replacements, etc.

What does a Buildings And Improvements of $ Mil mean?
Euroapi (EAPIF) has a Buildings And Improvements of $ Mil as of Jun. 2026. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Euroapi and its competitors.
Is Euroapi's Buildings And Improvements too high?
Euroapi's current Buildings And Improvements is $ Mil. Overall, Euroapi has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's Buildings And Improvements compare to ZTS and UTHR?
Euroapi's Buildings And Improvements of $ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buildings And Improvements for a Drug Manufacturers company?
A good Buildings And Improvements depends on the Drug Manufacturers industry context. However, Buildings And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buildings And Improvements mean?
A high Buildings And Improvements can signal that a stock is expensive relative to its fundamentals. Buildings and improvements is the total value of a company's buildings and improvements to them. View historical data on Euroapi and its competitors. Euroapi's current Buildings And Improvements is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (EAPIF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.97 — trading 65.9% below its estimated fair value. The current Buildings And Improvements is $ Mil. Euroapi's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buildings And Improvements calculated?
Buildings And Improvements is calculated from a company's financial statements. For Euroapi (EAPIF), the current Buildings And Improvements is $ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euroapi (EAPIF) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of $0.97 is trading 65.9% below its estimated GF Value™ of $2.84. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for EAPIF:

  • Buildings And Improvements: $ Mil
  • GF Value™: $2.84 vs. price of $0.97 (65.9% below fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the EAPIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA is a European pharmaceutical ingredients company spun off from Sanofi in 2022. It develops, manufactures, and supplies active pharmaceutical ingredients (APIs) and intermediates used in human and veterinary medicines, as well as for cosmetics. Its portfolio spans categories including vitamin B12, prostaglandins, oligonucleotides, peptides, corticosteroids and hormones, anti-infectives, opiates, and analgesics. The company serves originator pharmaceutical companies, generic drugmakers, and cosmetics firms, and also provides contract development and manufacturing organization (CDMO) services. Euroapi operates multiple industrial sites, primarily in France, Germany, Italy, the United Kingdom, and Hungary, giving it a broad European manufacturing footprint. Revenue comes from selling APIs and intermediates and from CDMO contracts, with a significant share tied to long-term supply agreements with Sanofi. The company is headquartered in Paris, France.
53GF Score

Get the complete analysis for EAPIF

Buildings And Improvements is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.97
Price
$2.84
GF Value